文献速递骨肿瘤小儿骨科

胫骨近端半关节置换重建能否有效减少骨骼未成熟原发骨肉瘤患者的肢体长度差异?

Is Proximal Tibial Hemiarthroplasty Reconstruction Effective in Minimizing Limb Length Discrepancy Among Skeletally Immature Patients With Primary Bone Sarcomas?
PubMed 文献 · Clin Orthop Relat Res · 2025-05-08

本研究回顾性分析2005至2022年单中心94例儿童胫骨近端原发恶性骨肿瘤患者,采用胫骨近端半关节置换重建。5年、10年无截肢生存率分别为96%和90%,10年假体无翻修生存率68%,MSTS-93评分平均83%,28%发生主要并发症。作者认为该术式是旋转铰链巨假体的合理替代,尤其适用于10岁及以上患儿,但需进一步对比研究。

要点

  • 胫骨近端半关节置换5年无截肢生存率96%(95%CI 91%-99%),10年90%(95%CI 81%-96%)。
  • 28%(26/94)患者发生主要并发症需再手术,10年假体无翻修生存率68%(95%CI 57%-79%)。
  • 年龄≤9岁与严重肢体长度差异(≥4 cm)风险增加相关(HR 7.3,95%CI 3.7-25.0,p=0.002)。

核心结论

  • 对于骨骼未成熟的胫骨近端肉瘤患者,胫骨近端半关节置换似乎是标准旋转铰链巨假体的一种合理替代方案,尤其适用于10岁及以上的儿童患者。
  • 该重建方式可保留股骨远端骨骺生长能力,从而可能减少最终肢体长度差异。
  • 选择儿童骨肉瘤胫骨近端切除后的重建方式时,应考虑患者年龄、骨骼成熟度、假体可及性、技术专长和术者偏好。
  • 本研究未比较使用可延长假体的儿童患者,未来研究应考虑对两种假体重建进行直接比较。

研究设计与样本

  • 本研究为回顾性研究,由北京积水潭医院(国家骨科医学中心)的四位顾问外科医生于2005年至2022年间实施。
  • 研究期间共883例原发恶性骨肿瘤患者可能符合条件,其中781例因接受保留关节的假体重建、回收自体骨移植或关节外切除而被排除,110例符合入选标准。
  • 110例中15%(16例)在最低2年随访前失访,最终85%(94例)纳入分析,平均随访7±4年。
  • 最常见诊断为骨肉瘤(97%[91/94])和尤文肉瘤(3%[3/94]);平均年龄11±2岁;57%(54/94)为男性。
  • 末次随访时,72%(68/94)无疾病证据,9%(8例)带瘤生存,18%(17例)因病死亡,1%(1例)死于其他原因。

主要发现

  • 所有患者5年和10年无截肢生存率分别为96%(95%CI 91%-99%)和90%(95%CI 81%-96%)。
  • 所有患者5年和10年假体无取出生存率分别为94%(95%CI 89%-99%)和85%(95%CI 75%-94%)。
  • 所有患者5年和10年假体无任何翻修生存率分别为86%(95%CI 77%-92%)和68%(95%CI 57%-79%)。
  • MSTS-93评分平均为83%±7%;28%(26/94)患者共接受28次再手术。
  • 3%(3/94)患者因膝关节半脱位(n=1)和无菌性松动(n=2)接受翻修,11%(10/94)因局部进展(n=7)和感染(n=3)接受假体翻修或截肢;无患者行骨骺阻滞。

关键数值与推荐

  • 多因素分析显示,同部位既往手术与膝关节半脱位风险增加相关(病因特异性HR 10,95%CI 5.2-59.0;p<0.001)。
  • 未使用内侧腓肠肌肌瓣与膝关节半脱位风险增加相关(病因特异性HR 7.1,95%CI 1.4-33.0;p=0.02)。
  • 手术时年龄≤9岁与严重肢体长度差异(≥4 cm)风险增加相关(病因特异性HR 7.3,95%CI 3.7-25.0;p=0.002)。

临床怎么用

  • 作者认为,对于骨骼未成熟的胫骨近端肉瘤患者,胫骨近端半关节置换似乎是标准旋转铰链巨假体的合理替代方案,尤其适用于10岁及以上的儿童患者。
  • 作者指出,选择儿童骨肉瘤胫骨近端切除后的重建方式时,应考虑患者年龄、骨骼成熟度、假体可及性、技术专长和术者偏好。

局限性

  • 本研究未比较使用可延长假体的儿童患者。
  • 未来研究应考虑对两种假体重建进行直接比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Proximal tibial resection and reconstruction with a hinged knee megaprostheses may result in severe limb length discrepancy (LLD) in very young children because of the removal of the distal femoral and proximal physis. An alternative reconstruction using a proximal tibial hemiarthroplasty reconstruction has been proposed and reduces the degree of LLD because the distal femoral physis is preserved. However, there are very few reports on the results from this reconstruction, and it is not certain that the disadvantages of a more unstable knee are outweighed by the possibility of reducing limb length inequality. QUESTIONS/PURPOSES: (1) What was the survivorship at 5 and 10 years after proximal tibial hemiarthroplasty reconstruction in children with malignant tumors, using amputation, endoprosthesis removal, and revision surgery as the main endpoints of interest? (2) What was the Musculoskeletal Tumor Society Score-93 (MSTS-93) after reconstruction at a minimum of 2 years after the procedure? (3) What percentage of patients experienced a major complication (resulting in unplanned reoperation), and what percentage of patients experienced minor complications (resulting in nonoperative treatment)? (4) What factors were associated with knee subluxation, and what factors were associated with an LLD measuring ≥ 4 cm? METHODS: This was a retrospective study performed by four consultant surgeons at a tertiary tumor referral center (Beijing Jishuitan Hospital, National Center for Orthopaedics, PR China) between 2005 and 2022. During that time, we generally recommended a tibial hemiarthroplasty to children with primary malignant tumors of the proximal tibia (Enneking stages IA, IB, and IIA and chemotherapy-responsive Stage IIB and IIIB tumors), as well as some metastatic tumors and some soft tissue sarcomas involving and surrounding the proximal tibia in children. We considered the ideal age range to be 9 to 13 years for males and 9 to 12 years for females, and we generally did not offer this procedure unless the surgeon believed that the neurovascular bundle was either uninvolved or could be separated during surgery. During that time, we considered 883 patients with primary malignant bone tumors to be potentially eligible. Of those, 781 were excluded because they underwent joint-preserving endoprosthetic reconstruction, recycled autografts, or extraarticular resection, leaving 110 who met the inclusion criteria for this study. Of those, 15% (16) of patients were lost to follow-up before the minimum follow-up of 2 years, leaving 85% (94) for analysis in this article at a mean ± SD follow-up time of 7 ± 4 years. The most common diagnoses were osteosarcoma (97% [91 of 94]) and Ewing sarcoma (3% [3 of 94]). The mean ± SD age was 11 ± 2 years; 57% (54 of 94) were male. At the last follow-up, 72% (68 of 94) of the patients had no evidence of disease, 9% (8) were alive with disease, 18% (17) had died of disease, and 1% (1) had died of other causes. Survivorship was estimated using the competing risk estimator, and data were presented at 5 and 10 years; outcome scores were derived from a longitudinally maintained institutional database. We reported on patients who developed major complications and underwent unplanned reoperation and minor complications that did not involve further surgery. Cox regression was used to evaluate the factors associated with knee subluxation and severe LLD (≥ 4 cm). RESULTS: Five-year and 10-year survival of the surgically treated limb free of amputation for all patients was 96% (95% confidence interval [CI] 91% to 99%) and 90% (95% CI 81% to 96%), respectively. The 5-year endoprosthesis removal-free survival rate for all patients was 94% (95% CI 89% to 99%), and the 10-year survival rate was 85% (95% CI 75% to 94%). The 5-year endoprosthetic survivorship free from any revision surgery for all patients was 86% (95% CI 77% to 92%), and the 10-year endoprosthetic survivorship was 68% (95% CI 57% to 79%). The mean ± SD MSTS-93 score was 83% ± 7%. Twenty-eight percent (26 of 94) of patients underwent a total of 28 reoperations. Three percent (3 of 94) of patients underwent revision for knee subluxation (n = 1) and aseptic loosening (n = 2), and 11% (10 of 94) of patients underwent endoprosthesis revision surgery or amputation for local progression (n = 7) and infection (n = 3). No patient had an epiphysiodesis. After controlling for confounding variables such as gender, endoprosthetic type, and mesh reconstruction, multivariate analysis showed that previous surgery at the same site (cause-specific HR 10 [95% CI 5.2 to 59.0]; p < 0.001) and not using medial gastrocnemius flaps (cause-specific HR 7.1 [95% CI 1.4 to 33.0]; p = 0.02) were associated with the increased risk of knee subluxation, whereas age at operation ≤ 9 years was associated with the increased risk of severe LLD (≥ 4 cm) (cause-specific HR 7.3 [95% CI 3.7 to 25.0]; p = 0.002). CONCLUSION: For skeletally immature patients with proximal tibial sarcomas, proximal tibial hemiarthroplasty appears to be a reasonable alternative to the standard rotating-hinge megaprosthesis, especially for pediatric patients age 10 years and older. This reconstruction can preserve the distal femoral epiphyseal growth capacity and thus potentially reduces final LLD. Moreover, patient age, skeletal maturity, implant availability, technical expertise, and surgeon preference should be considered when choosing a reconstructive approach after proximal tibial resection in children with osteosarcoma. This study did not compare pediatric patients treated with extendable prostheses. Future studies should consider direct comparisons between the two types of prosthetic reconstruction. LEVEL OF EVIDENCE: Level IV, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Li Z, Fan D, Zhao J, et al. Is Proximal Tibial Hemiarthroplasty Reconstruction Effective in Minimizing Limb Length Discrepancy Among Skeletally Immature Patients With Primary Bone Sarcomas? Clin Orthop Relat Res. 2025. PMID: 40359906. doi:10.1097/CORR.0000000000003543

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。